SlideShare a Scribd company logo
ISO 9001 Certified Organisation
TAMIL NADU MEDICAL SERVICES CORPORATION LTD
417 - IInd Floor, Pantheon Road, Egmore, Chennai – 600 008.
Phone : 28190259 / 28191890 / 28191891 Fax : 044 – 28190636
Email : enquiry@tnmsc.com
Website : www.tnmsc.com / http://tnmsc.tn.nic.in
TAMIL NADU MEDICAL SERVICES CORPORATION LTD
417 - IInd Floor, Pantheon Road, Egmore, Chennai – 600 008.
Phone : 28190259 / 28191890 / 28191891 Fax : 044 – 28190636
Email : enquiry@tnmsc.com
Website : www.tnmsc.com / http://tnmsc.tn.nic.in
Quality PolicyQuality Policy
        Tamil Nadu Medical Services Corporation Limited supports the Government MedicalTamil Nadu Medical Services Corporation Limited supports the Government Medical
Institutions in providing quality health care delivery system to the people of Tamil NaduInstitutions in providing quality health care delivery system to the people of Tamil Nadu..
We arrange to deliver on time high quality drugs, medicines, surgical and suture itemsWe arrange to deliver on time high quality drugs, medicines, surgical and suture items
to the Government Medical Institutions with courtesy and care for our customers.to the Government Medical Institutions with courtesy and care for our customers.
To achieve this objective we adopt a rational drug management system, abiding by theTo achieve this objective we adopt a rational drug management system, abiding by the
applicable laws of the land and other regulatory requirements pertaining to the drugsapplicable laws of the land and other regulatory requirements pertaining to the drugs
and medicines.and medicines.
We achieve our goal with involvement and empowerment of our personnel throughWe achieve our goal with involvement and empowerment of our personnel through
continually improving a Quality Management System established in accordance withcontinually improving a Quality Management System established in accordance with
ISO 9001:2000.ISO 9001:2000.
ProfileProfile
 Tamilnadu medical services corporation ltd..,(TNMSC)Tamilnadu medical services corporation ltd..,(TNMSC)
was incorporated under the Companies Act,1956 onwas incorporated under the Companies Act,1956 on
1/7/1994.1/7/1994.
 It has commenced its functions of purchase,storageIt has commenced its functions of purchase,storage
and distribution of drugs and medicines from Januaryand distribution of drugs and medicines from January
1995.1995.
 Its primary objective is to ensure ready availability ofIts primary objective is to ensure ready availability of
quality drugs and medicines in the Govt.Medicalquality drugs and medicines in the Govt.Medical
Institutions throughout the state.Institutions throughout the state.
BOARD OF DIRECTORSBOARD OF DIRECTORS
Chairman, TNMSC Ltd.,Chairman, TNMSC Ltd.,
Secretary, Health & Family Welfare DepartmentSecretary, Health & Family Welfare Department
Special Secretary, Finance DepartmentSpecial Secretary, Finance Department
Managing Director, TNMSC Ltd.,Managing Director, TNMSC Ltd.,
Project Director, Reproductive & Child Health ProjectProject Director, Reproductive & Child Health Project
Director of Medical EducationDirector of Medical Education
Director of Medical and Rural Health ServicesDirector of Medical and Rural Health Services
Director of Public Health & Preventive MedicineDirector of Public Health & Preventive Medicine
Director, Drug Control DepartmentDirector, Drug Control Department
Chief Engineer, Public Work Department (Buildings)Chief Engineer, Public Work Department (Buildings)
Organogram
MANAGING
DIRECTOR
Chief Accounts Officer/
Company Secretary
Senior Regional
Manager
Manager
(Quality Control)
Superintending
Engineer
Accounts
Construction
Work
24 Drug WarehousesE D P
Administration
Manager
(Purchase)
Purchase of
Equipments
Maintenance
of Equipments
Maintenance
of CT & MRI
Scan
CHAIRMAN
Superintending 
Engineer
Deputy 
Manager
AE 
(Electrical)
AE - 3
(Civil)
Senior Regional 
Manager
Drug 
Warehouse
Assistant
(Outsourced)
Manager 
(Purchase)
Pharmacists  -2
DEO             -1
Packers         -2
(Outsourced)
ENGINEERING SECTIONENGINEERING SECTION
PURCHASE SECTIONPURCHASE SECTION
Manager 
(Quality Control)
QC
Assistant
Assistant-2
Chief Accounts 
Officer
Assistant 
Accounts 
Officer - 2
Cashier Assistant
(Outsourced)
EDP Section
(Outsourced)
Systems Analyst – 1
Programmer       – 3
DEO                   – 7
Accounts Officer
Auditors –4
(Outsourced)
Company 
Secretary
Assistant Drivers               - 7
Security Persons - 50
(Outsourced)
DEO            -2
Receptionist- 1
Despatch     - 1
(Outsourced)
QUALITY CONTROLQUALITY CONTROL
SECTIONSECTION
ACCOUNTS SECTIONACCOUNTS SECTION
ADMINSTRATION SECTIONADMINSTRATION SECTION
Comparison Before andComparison Before and
After TNMSCAfter TNMSC
Purchase by Deans/JDs of thePurchase by Deans/JDs of the
hospitals through Open Tenderhospitals through Open Tender
Supply by dealersSupply by dealers
Supplies were made in bulkSupplies were made in bulk
quantities in loose form in bottles.quantities in loose form in bottles.
Effective Quality Control was notEffective Quality Control was not
possible as the quantity on everypossible as the quantity on every
purchase is low.purchase is low.
Quality deteriorationQuality deterioration
Purchase by TNMSC through openPurchase by TNMSC through open
Tender.Tender.
Supply by manufacturers / DirectSupply by manufacturers / Direct
importersimporters
Supplies are made in Strips/BlistersSupplies are made in Strips/Blisters
which is easy to handle.which is easy to handle.
Rigorous Quality control is done.Rigorous Quality control is done.
Each and every batch is tested.Each and every batch is tested.
No Quality deteriorationNo Quality deterioration
Different rates for the hospitalsDifferent rates for the hospitals
Payment to the supplier was donePayment to the supplier was done
from different sources.from different sources.
Rates are Higher.Rates are Higher.
Uniform rates for all the hospitals.Uniform rates for all the hospitals.
Payment from Single source.Payment from Single source.
Bulk Purchase – Rates areBulk Purchase – Rates are
competitive and Cheapercompetitive and Cheaper..
Comparison Before andComparison Before and
After TNMSCAfter TNMSC
Institutions Served by TNMSCInstitutions Served by TNMSC
 All Medical Teaching InstitutionsAll Medical Teaching Institutions 4242
 All District Head Quarters Hospital.All District Head Quarters Hospital. 2525
 All Taluk Head Quarters Hospital. 240All Taluk Head Quarters Hospital. 240
 All Primary Health Centers 1413All Primary Health Centers 1413
 All Health Sub Centers 8682All Health Sub Centers 8682
 All ESI Hospitals and Dispensaries 185All ESI Hospitals and Dispensaries 185
 All TNEB medical facilitiesAll TNEB medical facilities 2828
 All Panchayat Union DispensariesAll Panchayat Union Dispensaries 5151
 All Police Medical Facilities.All Police Medical Facilities. 1010
 Juvenile Homes.Juvenile Homes. 1010
 Prison and Rehabilitation homes.Prison and Rehabilitation homes. 1111
 Co-operative Sugar Factories.Co-operative Sugar Factories. 1818
 Veterinary Institutions. 285Veterinary Institutions. 285
 Transport Corporation Dispensaries.Transport Corporation Dispensaries. 1414
 All Local body Medical facilities.All Local body Medical facilities. 4545
Total 11059Total 11059
Budget
- Government makes budget allotment to Heads of departments
every year
- Heads of departments distribute this budget allotment to the
institutions based on which passbook is issued for lifting the
drugs.
- Heads of departments deposit 90% of this budget in the P.D.
Account of TNMSC for the purchase of drugs.
- TNMSC withdraws this amount as and when required for making
payment to the suppliers.
- Heads of departments allocate 10% of budget allotment to the
institutions for local purchase.
Value of Medicines Purchased during 2003-2004
Rs. in Lakhs
1142
1289
9711
Drugs
Surgical &
Suture
Veterinary
TNMSC’s TransactionsTNMSC’s Transactions
271 – DRUGS271 – DRUGS
92 – SUTURES92 – SUTURES
63 – SURGICALS63 – SURGICALS
133 –133 –
VETERINARYVETERINARY
No. of ItemsNo. of Items
Total Value Rs. 12142 LakhsTotal Value Rs. 12142 Lakhs
DRUG COMMITTEEDRUG COMMITTEE
Drug Committee consists of the following members.Drug Committee consists of the following members.
•Managing Director, TNMSC Ltd.Managing Director, TNMSC Ltd.
•Director of Medical EducationDirector of Medical Education
•Director of Medical and Rural Health ServicesDirector of Medical and Rural Health Services
•Director of Public Health and Preventive MedicineDirector of Public Health and Preventive Medicine
•Director of Family WelfareDirector of Family Welfare
•Director of Drug ControlDirector of Drug Control
•Professors of MedicineProfessors of Medicine
•Professors of SurgeryProfessors of Surgery
Purchase ProcedurePurchase Procedure
Drug committee discuss and decide about theDrug committee discuss and decide about the
drugs to be purchaseddrugs to be purchased
TenderTender
ProcessingProcessing
Invite Tender throughInvite Tender through
Press and WebsitePress and Website
Receipt & openReceipt & open
TenderTender
Signing ofSigning of
Agreement with SecurityAgreement with Security
DepositDeposit
Cover A OpeningCover A Opening
L1 RateL1 Rate
MatchingMatching
L1 RateL1 Rate
ProcessingProcessing
Issue of TenderIssue of Tender
DocumentDocument
Inspection ofInspection of
Manufacture unitManufacture unit
Evaluation ofEvaluation of
SamplesSamples
Cover B OpeningCover B Opening
DrugsDrugs
SurgicalSurgical
SutureSuture
Blood BankBlood Bank
11
22
33
44 55
66
66
77
88
99
1010
Issue of PurchaseIssue of Purchase
OrderOrder
1111
Tender ProcessTender Process
Drug committee to finalise the list of items (EssentialDrug committee to finalise the list of items (Essential
Drug List) and quantity for tenderDrug List) and quantity for tender
Advertisements:-Advertisements:-
♣ National Dailies through D.I.P.R.National Dailies through D.I.P.R.
♣ WebsitesWebsites
♣ Trade Journal like Pharma pulse, IDMATrade Journal like Pharma pulse, IDMA
♣ Letters to Drugs Controllers & Pharma AssociationLetters to Drugs Controllers & Pharma Association
Issue and receipt of Tender DocumentsIssue and receipt of Tender Documents
Tender CoverTender Cover ““AA”” openingopening
 Tender Committee.Tender Committee.
 Scrutinizing TeamScrutinizing Team
Inspection of the manufacturing premises of newInspection of the manufacturing premises of new
tenderers in case of drugstenderers in case of drugs
Evaluation of surgical/sutures samples by ExpertsEvaluation of surgical/sutures samples by Experts
SALIENT FEATURES INSALIENT FEATURES IN
COVER ‘A’COVER ‘A’
Licence for the product quotedLicence for the product quoted
Minimum three years market standingMinimum three years market standing
for the drug issued by the licensingfor the drug issued by the licensing
authorityauthority
Minimum turn over of Rs. 35 lakhsMinimum turn over of Rs. 35 lakhs
Non conviction certificate for threeNon conviction certificate for three
yearsyears
GMP certificateGMP certificate
SALIENT FEATURES INSALIENT FEATURES IN
COVER ‘B’COVER ‘B’
Printed format for quoting the landed pricePrinted format for quoting the landed price
excluding Sales Tax.excluding Sales Tax.
Printed format to furnish the break up detailsPrinted format to furnish the break up details
of landed priceof landed price
The tenderer is strictly prohibited toThe tenderer is strictly prohibited to
change /alter specification or unit size in thechange /alter specification or unit size in the
printed formatprinted format
The rate per unit(landed price)will be theThe rate per unit(landed price)will be the
criteria for determining the L1 ratecriteria for determining the L1 rate
The manufacturing capacity for each item forThe manufacturing capacity for each item for
effecting supplies to the warehouses withineffecting supplies to the warehouses within
60 days shall be given in the printed format60 days shall be given in the printed format
The above details of rates and capacity shallThe above details of rates and capacity shall
be given in computer floppybe given in computer floppy
TENDER CONDITIONSTENDER CONDITIONS
The tablet and capsule shall have the logogram inThe tablet and capsule shall have the logogram in
addition to the logogram on the strips/outer labelsaddition to the logogram on the strips/outer labels
The cap of the bottle shall not have the name of theThe cap of the bottle shall not have the name of the
manufacturermanufacturer
Samples of supplies in each batch will be chosen forSamples of supplies in each batch will be chosen for
testingtesting
The supply should be commenced within 30 days andThe supply should be commenced within 30 days and
completed within 60 dayscompleted within 60 days
Liquidated damages will be levied for delayed supplyLiquidated damages will be levied for delayed supply
(0.5% per day subject to a maximum of 15%)(0.5% per day subject to a maximum of 15%)
If the product fails in quality test , the entire batch willIf the product fails in quality test , the entire batch will
be returned to the supplier.be returned to the supplier.
 The Cover B of only those tenderers  who are      
eligible in Cover A and found eligible during 
inspection, are opened. 
 For surgical and suture items / blood bank 
consumables, the rates of only those items are 
considered where the sample has passed in clinical 
evaluation. 
Publication of L1 rates in the Website
L1 rates published on the same day on the Notice Board.
Cover "B” Opening
Drug DistributionDrug Distribution
TNMSCTNMSC
Head OfficeHead Office
Other InstitutionsOther Institutions
Medical InstitutionsMedical Institutions
Head of DeptHead of Dept
Ware HouseWare House
SupplierSupplier
Requirement
Requirement Requirement
Requirement
Purchase
O
rder
Purchase
O
rder
SuppliesSupplies
Supplies
Supplies
Indents
Indents
Issue of
Issue of
Passbooks
Passbooks
Paracetamol Tab 13.14 11.95 11.5 11.42 11.24 12.4
Co-Trimaxazole Tab 31 27.85 27.3 27.82 27.82 24.88
Cephataxime Sodium Inj 8.31 5.67 5.24 5.08 4.94 4.41
Ciprofloxacin Inj 8 7.5 7.2 6.75 6.74 6.41
Rantidine HCL Tab 31.2 28 26 23.9 22.34 22.05
Ciprofloxacin Tab 168 129.6 99.9 93.03 88 82
Omperazole Cap 86 67 49.9 44 38.57 33.08
Rate Comparison Details (Last 5 Years)
0
20
40
60
80
100
120
140
160
180
Drug Name
ValueinRs.
98-99 13.14 31 8.31 8 31.2 168 86
99-00 11.95 27.85 5.67 7.5 28 129.6 67
00-01 11.5 27.3 5.24 7.2 26 99.9 49.9
01-02 11.42 27.82 5.08 6.75 23.9 93.03 44
02-03 11.24 27.82 4.94 6.74 22.34 88 38.57
03-04 12.4 24.88 4.41 6.41 22.05 82 33.08
Paracetamol
Tab
Co-
Trimaxazole
Tab
Cephataxime
Sodium Inj
Ciprofloxacin
Inj
Rantidine
HCL Tab
Ciprofloxacin
Tab
Omperazole
Cap
Sl. No. DRUG NAME UNIT TNMSC AP KAR
1 Aspirin Tab. I.P. - 300 mg 10 X 10 Tabs 11.70 12.00 14.00
2 Prednisolone Tab. I.P. - 5 mg 10 X 10 Tabs 22.90 28.00 28.00
3 Acetazolamide Tab. I.P. - 250 mg 10 X 10 Tabs 41.13 54.00 58.00
4 Ketamine Inj. I.P. - 50 mg/ml 10 ml Vial 14.00 23.00 20.00
5 Thiopentone Sodium Inj. I.P. - 500 mg 20 ml Vial 15.50 26.00 30.00
6 Folic Acid Tab. I.P. - 5 mg 10 X 10 Tabs 5.86 6.00 6.00
7 Diethylcarbamazine Citrate Tab. I.P. - 100 mg 10 X 10 Tabs 7.35 8.00 11.00
8 Choloroquine Phosphate Tab. I.P. - 250 mg 10 X 10 Tabs 23.77 27.00 30.00
9 Silver Sulphadiazine Cream U.S.P. 50 gms Tube 6.03 21.00 16.00
10 Phenobarbitone Tab. I.P. - 30 mg 10 X 10 Tabs 7.66 12.00 10.00
11 ORS Powder I.P. Pouches 27.9 gms 1.56 1.58 1.58
12 Hydrocortisone Sodium Succinate Inj. I.P. - 100mg100 mg/Vial 9.27 12.00 11.00
13 Frusemide Tab. I.P. - 40 mg 10 X 10 Tabs 13.38 14.00 16.00
14 Frusemide Inj. I.P. - 10 mg/ml 2 ml Amp 0.76 0.86 0.95
15 Metaclopramide Inj. I.P. - 10 mg/2 ml 2 ml Amp 0.74 0.85 0.96
16 Rantidine Hcl Inj. I.P. - 50 mg/2 ml 2 ml Amp 0.76 0.82 0.90
17 Rantidine Hcl Tab. I.P. - 150 mg 10 X 10 Tabs 22.34 23.00 30.00
18 Metroniadazole Inj. I.P. - 500mg/100ml 100 ml FFS Bottle 5.25 6.25 6.75
19 Pheniramine Maleate Inj. I.P. (IM or Slow IV Inj.) 2 ml Amp 0.77 0.82 0.92
20 Peritonial Dialysis Solution I.P. - 1000 ml 1000 ml Bottle 13.45 14.25 18.00
COMPARISON OF RATES 2002-COMPARISON OF RATES 2002-
0303
Sl. No. DRUG NAME UNIT TNMSC AP KAR
21 Paracetamol Tab. I.P. - 500 mg 10 X 10 Tabs 11.24 13.00 14.00
22 Diazepam Tab. I.P. - 5 mg 10 X 10 Tabs 3.96 4.00 7.00
23 Dexamethasone Sodium Phosphate Inj. I.P. - 8mg/2ml2 ml Vial 2.10 3.00 3.75
24 Pentazocine Lactate Inj. I.P. - 30 mg/ml 1 ml Amp 2.82 2.95 3.10
25 Adrenaline Inj. I.P. - 1 mg/ml 1 ml Amp 0.84 0.92 0.92
26 Atropine Sulphate Inj. I.P. - 0.6 mg/1 ml 2 ml Amp 0.59 0.59 0.62
27 Chlorpheniramine Maleate Tab. I.P. - 4 mg 10 X 10 Tabs 2.40 3.20 4.20
28 Paracetamol Oral Solution U.S.P. XXII - 150 mg/ml15 ml Bottle 4.56 4.90 4.95
29 Ibuprofen Tab. I.P. - 400 mg 10 X 10 Tabs 22.60 24.00 23.00
30 Paracetamol Inj. - 150 mg/ml 2 ml Amp 0.92 0.95 0.96
31 Diclofenac Sodium Inj. I.P. - 25mg/ml 3 ml Amp 0.81 0.85 0.96
32 Glybenclamide Tab.I.P. - 5 mg 10 X 10 Tabs 5.19 8.25 9.00
33 Neostigmine Inj. I.P. - 0.5 mg/ml 0.5 mg/ml Amp 0.95 8.50 2.50
34 Ascorbic Acid Tab. I.P. - 100 mg 10 X 10 Tabs 10.62 43.00 38.00
35 Metformin Tab. I.P. - 500 mg 10 X 10 Tabs 15.90 17.50 16.50
36 Imipramine Tab. I.P. - 25 mg 10 X 10 Tabs 11.70 17.00 16.50
37 Haloperidol Tab. I.P. - 5 mg 10 X 10 Tabs 8.82 20.00 18.00
38 Lignocaine Hcl Inj. I.P. 30 ml Vial 2.95 2.75 7.75
39 Mannitol Inj. I.P. 350 ml Bottle 22.45 25.00 36.00
40 Bupivacaine Inj. I.P. 20 ml Vial 16.95 20.00 28.00
41 Ciprofloxacin Eye Drops U.S.P. 5 ml Vial 2.03 4.00 4.90
COMPARISON OF RATES 2002-COMPARISON OF RATES 2002-
0303
Thiruvannamalai Warehouse
Stock Accounting in Ware housesStock Accounting in Ware houses
• 1 – Inward Goods Register1 – Inward Goods Register
• 2 – Material Receipt Certificate (MRC)2 – Material Receipt Certificate (MRC)
• 3 – Q.C. Samples Outward3 – Q.C. Samples Outward
• 4 – Stock Register4 – Stock Register
• 5 – BIN Card5 – BIN Card
• 6 – Inward Indent/Issue Form6 – Inward Indent/Issue Form
• 7 – Outward Goods Register7 – Outward Goods Register
• 8 – Frozen Stock Register8 – Frozen Stock Register
QUALITYQUALITY CONTROLCONTROL
Samples from
Warehouses
Eliminating
Common
Batches
Sent to LAB
Receipt of
Results
QUALITY withQUALITY with
no Compromiseno Compromise
If Passed
Distribution to
Institutions
If Failed
return To supplier
If fails, samples
are sent to G.A. and another
lab for confirmation
DEDUCTION FOR QUALITY FAILUREDEDUCTION FOR QUALITY FAILURE
If the product fails in quality test, the product will not be accepted andIf the product fails in quality test, the product will not be accepted and
returned to the supplier.returned to the supplier.
Even if the field samples taken by the Drug Inspector fails in qualityEven if the field samples taken by the Drug Inspector fails in quality
test the cost of the quantity remaining unutilized will be recovered fromtest the cost of the quantity remaining unutilized will be recovered from
the supplier apart from the levying of other penalties / punishmentsthe supplier apart from the levying of other penalties / punishments
including blacklisting.including blacklisting.
If there is any complaint from the Medical Officer about the quality ofIf there is any complaint from the Medical Officer about the quality of
the product the remaining quantity in the particular batch will be returnedthe product the remaining quantity in the particular batch will be returned
to the supplier and value equal to the quantity returned will be recovered.to the supplier and value equal to the quantity returned will be recovered.
PROCEDURE FORPROCEDURE FOR
BLACKLISTINGBLACKLISTING
• In case during the contract period the supplier fails to execute threeIn case during the contract period the supplier fails to execute three
consecutive purchase orders issued in full within 90 days then theconsecutive purchase orders issued in full within 90 days then the
product will be blacklisted for the firm after giving due opportunity theproduct will be blacklisted for the firm after giving due opportunity the
firm to explain the reason for the non execution of purchase orders.firm to explain the reason for the non execution of purchase orders.
• During the contract period if two batches of the particular itemDuring the contract period if two batches of the particular item
supplied by the firm fails in quality test (Assay content) the product ofsupplied by the firm fails in quality test (Assay content) the product of
that particular firm will be blacklisted.that particular firm will be blacklisted.
• During the contract period if three batches of the particular itemDuring the contract period if three batches of the particular item
supplied by the firm fails in quality test (description test and othersupplied by the firm fails in quality test (description test and other
parameters mentioned in pharmocopeia / As per IS specification) thenparameters mentioned in pharmocopeia / As per IS specification) then
that particular item will be blacklisted for the firm.that particular item will be blacklisted for the firm.
• In respect of the firm supplying more than one item during theIn respect of the firm supplying more than one item during the
contract period if more than 50% of the items are blacklisted based oncontract period if more than 50% of the items are blacklisted based on
the above process then the firm will be blacklisted.the above process then the firm will be blacklisted.
 
Description 98-99 99-2000 2000-01 2001-02 2002-03
No. of Samples Sent to QC Lab 10065 10185 10476 11065 12012
No. of Samples Passed 9736 9874 10186 10824 11844
No. of Samples Failed 329 311 290 241 168
% Passed 96.73 96.94 97.23 97.82 98.60
% of Failure 3.26 3.05 2.76 2.17 1.40
 
Assessment of Samples Sent for QC TestAssessment of Samples Sent for QC Test
2003-04
14778
14600
178
98.8
1.20
Management InformationManagement Information
System-MISSystem-MIS
• Exceptional Stock Statement
• Slow Moving Drug List
• Drug Order Statement
• Passbook Utilisation Report
• Unexecuted Order Statement
• Abstract Pending Bills Report
• Time Expiry Drugs
• Abstract Order & Supplied Value Report
Diagnostics ServicesDiagnostics Services
  (i) ISO 9001:2000 certified GI Bleed and Hepatobiliary Centre(i) ISO 9001:2000 certified GI Bleed and Hepatobiliary Centre
(Special Ward) maintained by TNMSC is functioning as a(Special Ward) maintained by TNMSC is functioning as a
separate unit under the Surgical Gastroentrology Department inseparate unit under the Surgical Gastroentrology Department in
Government Stanley Hospital, Chennai.Government Stanley Hospital, Chennai.
(ii) TNMSC is maintaining the Master Health Checkup Scheme at(ii) TNMSC is maintaining the Master Health Checkup Scheme at
Government General Hospital, Chennai.Government General Hospital, Chennai.
(iii) TNMSC is maintaining the Special Class Maternity Ward in(iii) TNMSC is maintaining the Special Class Maternity Ward in
IOG, Chennai-8.IOG, Chennai-8.
(iv) TNMSC has provided infrastructure facilities to the payment(iv) TNMSC has provided infrastructure facilities to the payment
ward in Govt. Kasturba Gandhi Hospital, chennai-5 and startedward in Govt. Kasturba Gandhi Hospital, chennai-5 and started
maintaining the same from 03-05-2004.maintaining the same from 03-05-2004.
TNMSC CT Scan CenterTNMSC CT Scan Center
TNMSC is maintaining 36 CT Scan Centres inTNMSC is maintaining 36 CT Scan Centres in
Govt. Hospitals.Govt. Hospitals.
The following charges are collected for scanning.The following charges are collected for scanning.
Category Plain With ContrastCategory Plain With Contrast
Inpatients Rs. 350/- Rs. 550/-Inpatients Rs. 350/- Rs. 550/-
Outpatients Rs. 500/- Rs. 700/-Outpatients Rs. 500/- Rs. 700/-
TNMSC MRI Scan CenterTNMSC MRI Scan Center
TNMSC is maintaining 1.5 Tesla MRI atTNMSC is maintaining 1.5 Tesla MRI at
- Govt. General Hospital, Chennai.- Govt. General Hospital, Chennai.
- Govt. Rajaji Hospital, Madurai.- Govt. Rajaji Hospital, Madurai.
CategoryCategory PlainPlain With ContrastWith Contrast
Larger PartsLarger Parts Rs. 3500/- EachRs. 3500/- Each Rs. 5000/- EachRs. 5000/- Each
Smaller PartsSmaller Parts Rs. 2500/- EachRs. 2500/- Each Rs. 4000/- EachRs. 4000/- Each
Purchase and Supply ofPurchase and Supply of
equipments to hospitalsequipments to hospitals
TNMSC has finalized rate contract (CPC System) through openTNMSC has finalized rate contract (CPC System) through open
tender for the purchase of equipments & accessories required fortender for the purchase of equipments & accessories required for
19 departments in Government hospitals consisting of about 307819 departments in Government hospitals consisting of about 3078
items for the period 2002-2004. The medical institutions canitems for the period 2002-2004. The medical institutions can
directly place purchase orders with the approved firms for thedirectly place purchase orders with the approved firms for the
supply of required equipments and accessories at the approvedsupply of required equipments and accessories at the approved
rates depending upon the budget provision.rates depending upon the budget provision.
The medical equipments required for the governmentThe medical equipments required for the government
hospitals are procured and supplied by TNMSC based onhospitals are procured and supplied by TNMSC based on
the Government order issued for this purpose from time tothe Government order issued for this purpose from time to
timetime
Construction Activities ofConstruction Activities of
TNMSCTNMSC
(i) Implementation of World Bank Assisted RCH Project(i) Implementation of World Bank Assisted RCH Project
   Under this project, construction of Buildings for 8 UHPs and 21 HSCs andUnder this project, construction of Buildings for 8 UHPs and 21 HSCs and
improvement works in 35 PHCs and 70 HSCs for Rs.5.65 Crores have beenimprovement works in 35 PHCs and 70 HSCs for Rs.5.65 Crores have been
completed by TNMSC in Madurai & Theni Districts.completed by TNMSC in Madurai & Theni Districts.
   (ii) Regional Diagnostic Centres(ii) Regional Diagnostic Centres
   TNMSC has established 7 Regional Diagnostic centres in the State (BuildingTNMSC has established 7 Regional Diagnostic centres in the State (Building
and Equipment) at Thiruvannamalai, Villupuram, Pudukottai, Virudhunagar,and Equipment) at Thiruvannamalai, Villupuram, Pudukottai, Virudhunagar,
Ramanathapuram, Nammakkal and Tiruppur at a total cost of Rs.21.00 CroresRamanathapuram, Nammakkal and Tiruppur at a total cost of Rs.21.00 Crores
funded by the Government of India.funded by the Government of India.
(iii) Accident and Emergency Ward (Trauma Care Centre)(iii) Accident and Emergency Ward (Trauma Care Centre)
Construction and procurement of equipments for the Accident and EmergencyConstruction and procurement of equipments for the Accident and Emergency
ward at Ambur, Krishnagiri, Tindivanam, Sriperumbudur and Kovilpatti have beenward at Ambur, Krishnagiri, Tindivanam, Sriperumbudur and Kovilpatti have been
completed at a cost of Rs.2.93 Crores provided by the Home Department.completed at a cost of Rs.2.93 Crores provided by the Home Department.
Consultancy ServicesConsultancy Services
TNMSC is a Role Model for other states of India onTNMSC is a Role Model for other states of India on
Drug Logistics and Warehousing.Drug Logistics and Warehousing.
TNMSC has taken up and completed the consultancyTNMSC has taken up and completed the consultancy
project for the preparation of Feasibility report forproject for the preparation of Feasibility report for
Andhra Pradesh.Andhra Pradesh.
Govt. of Rajasthan has entrusted preparation ofGovt. of Rajasthan has entrusted preparation of
feasibility report to TNMSC. Draft Final reportfeasibility report to TNMSC. Draft Final report
submitted to Govt. of Rajasthan.submitted to Govt. of Rajasthan.
Training course on Drug Logistics and WarehousingTraining course on Drug Logistics and Warehousing
has been conducted for Pharmacists, H & FWhas been conducted for Pharmacists, H & FW
department , Govt. of Karnataka during May 2003department , Govt. of Karnataka during May 2003
and for Pharmacists, H & FW department , Govt. ofand for Pharmacists, H & FW department , Govt. of
Assam during June 2004.Assam during June 2004.
ThanksThanks
Email me : arputhaselvaraj@gmail.comEmail me : arputhaselvaraj@gmail.com

More Related Content

What's hot

Ranbaxy company profile
Ranbaxy company profileRanbaxy company profile
Ranbaxy company profile
sanath_mahadi
 
Drug and cosmetic act 1940
Drug and cosmetic act 1940Drug and cosmetic act 1940
Drug and cosmetic act 1940
Shubhankur Bhardwaj
 
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh AlemiPharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Rajashri Survase Ojha
 
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Greenlight Guru
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
sandeep bansal
 
Salud laboratorio
Salud laboratorioSalud laboratorio
Salud laboratorio
Ariel Aranda
 
CDSCO and ADR reporting in India
CDSCO and ADR reporting in IndiaCDSCO and ADR reporting in India
CDSCO and ADR reporting in India
kiran pala
 
Nutraceuticals - Business Opportunities
Nutraceuticals - Business OpportunitiesNutraceuticals - Business Opportunities
Nutraceuticals - Business Opportunities
primary information services
 
Qms (6 sigma concepts) six sigma concept
Qms (6 sigma concepts) six sigma conceptQms (6 sigma concepts) six sigma concept
Qms (6 sigma concepts) six sigma concept
Dr Ajay Kumar Tiwari
 
The Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherdeThe Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherde
mithun.kherde
 
Schedule y, mk sharma
Schedule y, mk sharmaSchedule y, mk sharma
Schedule y, mk sharma
SHARDA UNIVERSITY
 
Clinicalestablishmentact dr.dikshit
Clinicalestablishmentact dr.dikshitClinicalestablishmentact dr.dikshit
Clinicalestablishmentact dr.dikshit
Rajive Dikshit
 
NABH Extended
NABH Extended NABH Extended
NABH Extended
Vijay Raj Yanamala
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countries
JAYA PRAKASH VELUCHURI
 
Project report titles for mba in hospital administration
Project report titles for mba in hospital administrationProject report titles for mba in hospital administration
Project report titles for mba in hospital administration
mbaprojectconsultacy2014
 
NABH
NABHNABH
Irda and Tpa in healthcare
Irda and Tpa in healthcareIrda and Tpa in healthcare
Irda and Tpa in healthcare
DrArshpreet18
 
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
DeveshDRA
 
JAN AUSHADHI SCHEME DETAILS.
JAN AUSHADHI SCHEME DETAILS.JAN AUSHADHI SCHEME DETAILS.
JAN AUSHADHI SCHEME DETAILS.
GK Dutta
 

What's hot (20)

Ranbaxy company profile
Ranbaxy company profileRanbaxy company profile
Ranbaxy company profile
 
Drug and cosmetic act 1940
Drug and cosmetic act 1940Drug and cosmetic act 1940
Drug and cosmetic act 1940
 
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh AlemiPharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
 
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
Understanding the Medical device Single Audit Program (MDSAP) & How to Prepar...
 
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...regulatory requirnment and approval procedure for drugs and cosmetics, medica...
regulatory requirnment and approval procedure for drugs and cosmetics, medica...
 
Salud laboratorio
Salud laboratorioSalud laboratorio
Salud laboratorio
 
CDSCO and ADR reporting in India
CDSCO and ADR reporting in IndiaCDSCO and ADR reporting in India
CDSCO and ADR reporting in India
 
Nutraceuticals - Business Opportunities
Nutraceuticals - Business OpportunitiesNutraceuticals - Business Opportunities
Nutraceuticals - Business Opportunities
 
Qms (6 sigma concepts) six sigma concept
Qms (6 sigma concepts) six sigma conceptQms (6 sigma concepts) six sigma concept
Qms (6 sigma concepts) six sigma concept
 
The Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherdeThe Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherde
 
Schedule y, mk sharma
Schedule y, mk sharmaSchedule y, mk sharma
Schedule y, mk sharma
 
Clinicalestablishmentact dr.dikshit
Clinicalestablishmentact dr.dikshitClinicalestablishmentact dr.dikshit
Clinicalestablishmentact dr.dikshit
 
NABH Extended
NABH Extended NABH Extended
NABH Extended
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countries
 
Project report titles for mba in hospital administration
Project report titles for mba in hospital administrationProject report titles for mba in hospital administration
Project report titles for mba in hospital administration
 
NABH
NABHNABH
NABH
 
Irda and Tpa in healthcare
Irda and Tpa in healthcareIrda and Tpa in healthcare
Irda and Tpa in healthcare
 
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...Comparative Study of Dossier Compilation & Submission Process of Drug Product...
Comparative Study of Dossier Compilation & Submission Process of Drug Product...
 
JAN AUSHADHI SCHEME DETAILS.
JAN AUSHADHI SCHEME DETAILS.JAN AUSHADHI SCHEME DETAILS.
JAN AUSHADHI SCHEME DETAILS.
 

Similar to TNMSC

Therapeutic Good Administration
Therapeutic Good AdministrationTherapeutic Good Administration
Therapeutic Good Administration
SAKSHI YADAV
 
Human resources for health
Human resources for healthHuman resources for health
Human resources for health
Nursing Hi Nursing
 
Therapeutic goods adminstration
Therapeutic goods adminstration   Therapeutic goods adminstration
Therapeutic goods adminstration
Pranali Palandurkar
 
Ayushman Hospital and Health Service
Ayushman Hospital and Health ServiceAyushman Hospital and Health Service
Ayushman Hospital and Health Service
AyushmanHospital
 
دليل المستهلكات و المستلزمات الطبية
دليل المستهلكات و المستلزمات الطبيةدليل المستهلكات و المستلزمات الطبية
دليل المستهلكات و المستلزمات الطبية
jamal afaneh
 
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.SrinivasaRegulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
Srinivas college of pharmacy, Mangalore
 
Nppa
NppaNppa
Nppa
bdvfgbdhg
 
Therapeutic Goods Administration
Therapeutic Goods Administration Therapeutic Goods Administration
Therapeutic Goods Administration
MAHARNABPRADHANVP21P
 
Brochure_01072016
Brochure_01072016Brochure_01072016
Brochure_01072016
Dipali Mahadik
 
Diagnostics & Healthcare
Diagnostics & HealthcareDiagnostics & Healthcare
Diagnostics & Healthcare
Jayashree Prabhu
 
Regulatory Issues
Regulatory IssuesRegulatory Issues
Regulatory Issues
Dr. Siddhi Upadhyay
 
Ruth Skinner-Smith - Resume - July 2016
Ruth Skinner-Smith - Resume - July 2016Ruth Skinner-Smith - Resume - July 2016
Ruth Skinner-Smith - Resume - July 2016
Ruth Skinner-Smith
 
DIT Education Presentation Athlone
DIT Education Presentation AthloneDIT Education Presentation Athlone
DIT Education Presentation Athlone
jen0m
 
Reg summary
Reg summaryReg summary
Reg summary
ruyang89
 
Medical Devices , regulations and e health solutions
Medical Devices , regulations and e health solutionsMedical Devices , regulations and e health solutions
Medical Devices , regulations and e health solutions
shashi sinha
 
Regulatory affairs by Aneela Saleem
Regulatory affairs by Aneela SaleemRegulatory affairs by Aneela Saleem
Regulatory affairs by Aneela Saleem
AneelaSaleem
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
Shaik Sana
 
KOHN TULI Alejandro Resume CMO V1
KOHN TULI Alejandro Resume CMO V1KOHN TULI Alejandro Resume CMO V1
KOHN TULI Alejandro Resume CMO V1
Alejandro Kohn Tuli
 
Regulatory System for Food Claims in China 2012
Regulatory System for Food Claims in China 2012Regulatory System for Food Claims in China 2012
Regulatory System for Food Claims in China 2012
Asian Food Regulation Information Service
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
Siddharth Kumar Sahu
 

Similar to TNMSC (20)

Therapeutic Good Administration
Therapeutic Good AdministrationTherapeutic Good Administration
Therapeutic Good Administration
 
Human resources for health
Human resources for healthHuman resources for health
Human resources for health
 
Therapeutic goods adminstration
Therapeutic goods adminstration   Therapeutic goods adminstration
Therapeutic goods adminstration
 
Ayushman Hospital and Health Service
Ayushman Hospital and Health ServiceAyushman Hospital and Health Service
Ayushman Hospital and Health Service
 
دليل المستهلكات و المستلزمات الطبية
دليل المستهلكات و المستلزمات الطبيةدليل المستهلكات و المستلزمات الطبية
دليل المستهلكات و المستلزمات الطبية
 
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.SrinivasaRegulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
 
Nppa
NppaNppa
Nppa
 
Therapeutic Goods Administration
Therapeutic Goods Administration Therapeutic Goods Administration
Therapeutic Goods Administration
 
Brochure_01072016
Brochure_01072016Brochure_01072016
Brochure_01072016
 
Diagnostics & Healthcare
Diagnostics & HealthcareDiagnostics & Healthcare
Diagnostics & Healthcare
 
Regulatory Issues
Regulatory IssuesRegulatory Issues
Regulatory Issues
 
Ruth Skinner-Smith - Resume - July 2016
Ruth Skinner-Smith - Resume - July 2016Ruth Skinner-Smith - Resume - July 2016
Ruth Skinner-Smith - Resume - July 2016
 
DIT Education Presentation Athlone
DIT Education Presentation AthloneDIT Education Presentation Athlone
DIT Education Presentation Athlone
 
Reg summary
Reg summaryReg summary
Reg summary
 
Medical Devices , regulations and e health solutions
Medical Devices , regulations and e health solutionsMedical Devices , regulations and e health solutions
Medical Devices , regulations and e health solutions
 
Regulatory affairs by Aneela Saleem
Regulatory affairs by Aneela SaleemRegulatory affairs by Aneela Saleem
Regulatory affairs by Aneela Saleem
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
 
KOHN TULI Alejandro Resume CMO V1
KOHN TULI Alejandro Resume CMO V1KOHN TULI Alejandro Resume CMO V1
KOHN TULI Alejandro Resume CMO V1
 
Regulatory System for Food Claims in China 2012
Regulatory System for Food Claims in China 2012Regulatory System for Food Claims in China 2012
Regulatory System for Food Claims in China 2012
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
 

Recently uploaded

Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
EduSkills OECD
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
haiqairshad
 
CIS 4200-02 Group 1 Final Project Report (1).pdf
CIS 4200-02 Group 1 Final Project Report (1).pdfCIS 4200-02 Group 1 Final Project Report (1).pdf
CIS 4200-02 Group 1 Final Project Report (1).pdf
blueshagoo1
 
CHUYÊN ĐỀ ÔN TẬP VÀ PHÁT TRIỂN CÂU HỎI TRONG ĐỀ MINH HỌA THI TỐT NGHIỆP THPT ...
CHUYÊN ĐỀ ÔN TẬP VÀ PHÁT TRIỂN CÂU HỎI TRONG ĐỀ MINH HỌA THI TỐT NGHIỆP THPT ...CHUYÊN ĐỀ ÔN TẬP VÀ PHÁT TRIỂN CÂU HỎI TRONG ĐỀ MINH HỌA THI TỐT NGHIỆP THPT ...
CHUYÊN ĐỀ ÔN TẬP VÀ PHÁT TRIỂN CÂU HỎI TRONG ĐỀ MINH HỌA THI TỐT NGHIỆP THPT ...
Nguyen Thanh Tu Collection
 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
PsychoTech Services
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
سمير بسيوني
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
Nguyen Thanh Tu Collection
 
skeleton System.pdf (skeleton system wow)
skeleton System.pdf (skeleton system wow)skeleton System.pdf (skeleton system wow)
skeleton System.pdf (skeleton system wow)
Mohammad Al-Dhahabi
 
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptxCapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
CapitolTechU
 
Educational Technology in the Health Sciences
Educational Technology in the Health SciencesEducational Technology in the Health Sciences
Educational Technology in the Health Sciences
Iris Thiele Isip-Tan
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
TechSoup
 
SWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptxSWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptx
zuzanka
 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Henry Hollis
 
Juneteenth Freedom Day 2024 David Douglas School District
Juneteenth Freedom Day 2024 David Douglas School DistrictJuneteenth Freedom Day 2024 David Douglas School District
Juneteenth Freedom Day 2024 David Douglas School District
David Douglas School District
 
How to Download & Install Module From the Odoo App Store in Odoo 17
How to Download & Install Module From the Odoo App Store in Odoo 17How to Download & Install Module From the Odoo App Store in Odoo 17
How to Download & Install Module From the Odoo App Store in Odoo 17
Celine George
 
MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025
khuleseema60
 
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
Himanshu Rai
 
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
TechSoup
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
Nguyen Thanh Tu Collection
 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
giancarloi8888
 

Recently uploaded (20)

Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
 
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skillsspot a liar (Haiqa 146).pptx Technical writhing and presentation skills
spot a liar (Haiqa 146).pptx Technical writhing and presentation skills
 
CIS 4200-02 Group 1 Final Project Report (1).pdf
CIS 4200-02 Group 1 Final Project Report (1).pdfCIS 4200-02 Group 1 Final Project Report (1).pdf
CIS 4200-02 Group 1 Final Project Report (1).pdf
 
CHUYÊN ĐỀ ÔN TẬP VÀ PHÁT TRIỂN CÂU HỎI TRONG ĐỀ MINH HỌA THI TỐT NGHIỆP THPT ...
CHUYÊN ĐỀ ÔN TẬP VÀ PHÁT TRIỂN CÂU HỎI TRONG ĐỀ MINH HỌA THI TỐT NGHIỆP THPT ...CHUYÊN ĐỀ ÔN TẬP VÀ PHÁT TRIỂN CÂU HỎI TRONG ĐỀ MINH HỌA THI TỐT NGHIỆP THPT ...
CHUYÊN ĐỀ ÔN TẬP VÀ PHÁT TRIỂN CÂU HỎI TRONG ĐỀ MINH HỌA THI TỐT NGHIỆP THPT ...
 
Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...Gender and Mental Health - Counselling and Family Therapy Applications and In...
Gender and Mental Health - Counselling and Family Therapy Applications and In...
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
 
skeleton System.pdf (skeleton system wow)
skeleton System.pdf (skeleton system wow)skeleton System.pdf (skeleton system wow)
skeleton System.pdf (skeleton system wow)
 
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptxCapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
 
Educational Technology in the Health Sciences
Educational Technology in the Health SciencesEducational Technology in the Health Sciences
Educational Technology in the Health Sciences
 
Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
 
SWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptxSWOT analysis in the project Keeping the Memory @live.pptx
SWOT analysis in the project Keeping the Memory @live.pptx
 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
 
Juneteenth Freedom Day 2024 David Douglas School District
Juneteenth Freedom Day 2024 David Douglas School DistrictJuneteenth Freedom Day 2024 David Douglas School District
Juneteenth Freedom Day 2024 David Douglas School District
 
How to Download & Install Module From the Odoo App Store in Odoo 17
How to Download & Install Module From the Odoo App Store in Odoo 17How to Download & Install Module From the Odoo App Store in Odoo 17
How to Download & Install Module From the Odoo App Store in Odoo 17
 
MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025MDP on air pollution of class 8 year 2024-2025
MDP on air pollution of class 8 year 2024-2025
 
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem studentsRHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
RHEOLOGY Physical pharmaceutics-II notes for B.pharm 4th sem students
 
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
 

TNMSC

  • 1. ISO 9001 Certified Organisation TAMIL NADU MEDICAL SERVICES CORPORATION LTD 417 - IInd Floor, Pantheon Road, Egmore, Chennai – 600 008. Phone : 28190259 / 28191890 / 28191891 Fax : 044 – 28190636 Email : enquiry@tnmsc.com Website : www.tnmsc.com / http://tnmsc.tn.nic.in TAMIL NADU MEDICAL SERVICES CORPORATION LTD 417 - IInd Floor, Pantheon Road, Egmore, Chennai – 600 008. Phone : 28190259 / 28191890 / 28191891 Fax : 044 – 28190636 Email : enquiry@tnmsc.com Website : www.tnmsc.com / http://tnmsc.tn.nic.in
  • 2. Quality PolicyQuality Policy         Tamil Nadu Medical Services Corporation Limited supports the Government MedicalTamil Nadu Medical Services Corporation Limited supports the Government Medical Institutions in providing quality health care delivery system to the people of Tamil NaduInstitutions in providing quality health care delivery system to the people of Tamil Nadu.. We arrange to deliver on time high quality drugs, medicines, surgical and suture itemsWe arrange to deliver on time high quality drugs, medicines, surgical and suture items to the Government Medical Institutions with courtesy and care for our customers.to the Government Medical Institutions with courtesy and care for our customers. To achieve this objective we adopt a rational drug management system, abiding by theTo achieve this objective we adopt a rational drug management system, abiding by the applicable laws of the land and other regulatory requirements pertaining to the drugsapplicable laws of the land and other regulatory requirements pertaining to the drugs and medicines.and medicines. We achieve our goal with involvement and empowerment of our personnel throughWe achieve our goal with involvement and empowerment of our personnel through continually improving a Quality Management System established in accordance withcontinually improving a Quality Management System established in accordance with ISO 9001:2000.ISO 9001:2000.
  • 3. ProfileProfile  Tamilnadu medical services corporation ltd..,(TNMSC)Tamilnadu medical services corporation ltd..,(TNMSC) was incorporated under the Companies Act,1956 onwas incorporated under the Companies Act,1956 on 1/7/1994.1/7/1994.  It has commenced its functions of purchase,storageIt has commenced its functions of purchase,storage and distribution of drugs and medicines from Januaryand distribution of drugs and medicines from January 1995.1995.  Its primary objective is to ensure ready availability ofIts primary objective is to ensure ready availability of quality drugs and medicines in the Govt.Medicalquality drugs and medicines in the Govt.Medical Institutions throughout the state.Institutions throughout the state.
  • 4. BOARD OF DIRECTORSBOARD OF DIRECTORS Chairman, TNMSC Ltd.,Chairman, TNMSC Ltd., Secretary, Health & Family Welfare DepartmentSecretary, Health & Family Welfare Department Special Secretary, Finance DepartmentSpecial Secretary, Finance Department Managing Director, TNMSC Ltd.,Managing Director, TNMSC Ltd., Project Director, Reproductive & Child Health ProjectProject Director, Reproductive & Child Health Project Director of Medical EducationDirector of Medical Education Director of Medical and Rural Health ServicesDirector of Medical and Rural Health Services Director of Public Health & Preventive MedicineDirector of Public Health & Preventive Medicine Director, Drug Control DepartmentDirector, Drug Control Department Chief Engineer, Public Work Department (Buildings)Chief Engineer, Public Work Department (Buildings)
  • 5. Organogram MANAGING DIRECTOR Chief Accounts Officer/ Company Secretary Senior Regional Manager Manager (Quality Control) Superintending Engineer Accounts Construction Work 24 Drug WarehousesE D P Administration Manager (Purchase) Purchase of Equipments Maintenance of Equipments Maintenance of CT & MRI Scan CHAIRMAN
  • 8. Comparison Before andComparison Before and After TNMSCAfter TNMSC Purchase by Deans/JDs of thePurchase by Deans/JDs of the hospitals through Open Tenderhospitals through Open Tender Supply by dealersSupply by dealers Supplies were made in bulkSupplies were made in bulk quantities in loose form in bottles.quantities in loose form in bottles. Effective Quality Control was notEffective Quality Control was not possible as the quantity on everypossible as the quantity on every purchase is low.purchase is low. Quality deteriorationQuality deterioration Purchase by TNMSC through openPurchase by TNMSC through open Tender.Tender. Supply by manufacturers / DirectSupply by manufacturers / Direct importersimporters Supplies are made in Strips/BlistersSupplies are made in Strips/Blisters which is easy to handle.which is easy to handle. Rigorous Quality control is done.Rigorous Quality control is done. Each and every batch is tested.Each and every batch is tested. No Quality deteriorationNo Quality deterioration
  • 9. Different rates for the hospitalsDifferent rates for the hospitals Payment to the supplier was donePayment to the supplier was done from different sources.from different sources. Rates are Higher.Rates are Higher. Uniform rates for all the hospitals.Uniform rates for all the hospitals. Payment from Single source.Payment from Single source. Bulk Purchase – Rates areBulk Purchase – Rates are competitive and Cheapercompetitive and Cheaper.. Comparison Before andComparison Before and After TNMSCAfter TNMSC
  • 10. Institutions Served by TNMSCInstitutions Served by TNMSC  All Medical Teaching InstitutionsAll Medical Teaching Institutions 4242  All District Head Quarters Hospital.All District Head Quarters Hospital. 2525  All Taluk Head Quarters Hospital. 240All Taluk Head Quarters Hospital. 240  All Primary Health Centers 1413All Primary Health Centers 1413  All Health Sub Centers 8682All Health Sub Centers 8682  All ESI Hospitals and Dispensaries 185All ESI Hospitals and Dispensaries 185  All TNEB medical facilitiesAll TNEB medical facilities 2828  All Panchayat Union DispensariesAll Panchayat Union Dispensaries 5151  All Police Medical Facilities.All Police Medical Facilities. 1010  Juvenile Homes.Juvenile Homes. 1010  Prison and Rehabilitation homes.Prison and Rehabilitation homes. 1111  Co-operative Sugar Factories.Co-operative Sugar Factories. 1818  Veterinary Institutions. 285Veterinary Institutions. 285  Transport Corporation Dispensaries.Transport Corporation Dispensaries. 1414  All Local body Medical facilities.All Local body Medical facilities. 4545 Total 11059Total 11059
  • 11. Budget - Government makes budget allotment to Heads of departments every year - Heads of departments distribute this budget allotment to the institutions based on which passbook is issued for lifting the drugs. - Heads of departments deposit 90% of this budget in the P.D. Account of TNMSC for the purchase of drugs. - TNMSC withdraws this amount as and when required for making payment to the suppliers. - Heads of departments allocate 10% of budget allotment to the institutions for local purchase.
  • 12. Value of Medicines Purchased during 2003-2004 Rs. in Lakhs 1142 1289 9711 Drugs Surgical & Suture Veterinary TNMSC’s TransactionsTNMSC’s Transactions 271 – DRUGS271 – DRUGS 92 – SUTURES92 – SUTURES 63 – SURGICALS63 – SURGICALS 133 –133 – VETERINARYVETERINARY No. of ItemsNo. of Items Total Value Rs. 12142 LakhsTotal Value Rs. 12142 Lakhs
  • 13. DRUG COMMITTEEDRUG COMMITTEE Drug Committee consists of the following members.Drug Committee consists of the following members. •Managing Director, TNMSC Ltd.Managing Director, TNMSC Ltd. •Director of Medical EducationDirector of Medical Education •Director of Medical and Rural Health ServicesDirector of Medical and Rural Health Services •Director of Public Health and Preventive MedicineDirector of Public Health and Preventive Medicine •Director of Family WelfareDirector of Family Welfare •Director of Drug ControlDirector of Drug Control •Professors of MedicineProfessors of Medicine •Professors of SurgeryProfessors of Surgery
  • 14. Purchase ProcedurePurchase Procedure Drug committee discuss and decide about theDrug committee discuss and decide about the drugs to be purchaseddrugs to be purchased TenderTender ProcessingProcessing Invite Tender throughInvite Tender through Press and WebsitePress and Website Receipt & openReceipt & open TenderTender Signing ofSigning of Agreement with SecurityAgreement with Security DepositDeposit Cover A OpeningCover A Opening L1 RateL1 Rate MatchingMatching L1 RateL1 Rate ProcessingProcessing Issue of TenderIssue of Tender DocumentDocument Inspection ofInspection of Manufacture unitManufacture unit Evaluation ofEvaluation of SamplesSamples Cover B OpeningCover B Opening DrugsDrugs SurgicalSurgical SutureSuture Blood BankBlood Bank 11 22 33 44 55 66 66 77 88 99 1010 Issue of PurchaseIssue of Purchase OrderOrder 1111
  • 15. Tender ProcessTender Process Drug committee to finalise the list of items (EssentialDrug committee to finalise the list of items (Essential Drug List) and quantity for tenderDrug List) and quantity for tender Advertisements:-Advertisements:- ♣ National Dailies through D.I.P.R.National Dailies through D.I.P.R. ♣ WebsitesWebsites ♣ Trade Journal like Pharma pulse, IDMATrade Journal like Pharma pulse, IDMA ♣ Letters to Drugs Controllers & Pharma AssociationLetters to Drugs Controllers & Pharma Association Issue and receipt of Tender DocumentsIssue and receipt of Tender Documents Tender CoverTender Cover ““AA”” openingopening  Tender Committee.Tender Committee.  Scrutinizing TeamScrutinizing Team Inspection of the manufacturing premises of newInspection of the manufacturing premises of new tenderers in case of drugstenderers in case of drugs Evaluation of surgical/sutures samples by ExpertsEvaluation of surgical/sutures samples by Experts
  • 16. SALIENT FEATURES INSALIENT FEATURES IN COVER ‘A’COVER ‘A’ Licence for the product quotedLicence for the product quoted Minimum three years market standingMinimum three years market standing for the drug issued by the licensingfor the drug issued by the licensing authorityauthority Minimum turn over of Rs. 35 lakhsMinimum turn over of Rs. 35 lakhs Non conviction certificate for threeNon conviction certificate for three yearsyears GMP certificateGMP certificate
  • 17. SALIENT FEATURES INSALIENT FEATURES IN COVER ‘B’COVER ‘B’ Printed format for quoting the landed pricePrinted format for quoting the landed price excluding Sales Tax.excluding Sales Tax. Printed format to furnish the break up detailsPrinted format to furnish the break up details of landed priceof landed price The tenderer is strictly prohibited toThe tenderer is strictly prohibited to change /alter specification or unit size in thechange /alter specification or unit size in the printed formatprinted format The rate per unit(landed price)will be theThe rate per unit(landed price)will be the criteria for determining the L1 ratecriteria for determining the L1 rate The manufacturing capacity for each item forThe manufacturing capacity for each item for effecting supplies to the warehouses withineffecting supplies to the warehouses within 60 days shall be given in the printed format60 days shall be given in the printed format The above details of rates and capacity shallThe above details of rates and capacity shall be given in computer floppybe given in computer floppy
  • 18. TENDER CONDITIONSTENDER CONDITIONS The tablet and capsule shall have the logogram inThe tablet and capsule shall have the logogram in addition to the logogram on the strips/outer labelsaddition to the logogram on the strips/outer labels The cap of the bottle shall not have the name of theThe cap of the bottle shall not have the name of the manufacturermanufacturer Samples of supplies in each batch will be chosen forSamples of supplies in each batch will be chosen for testingtesting The supply should be commenced within 30 days andThe supply should be commenced within 30 days and completed within 60 dayscompleted within 60 days Liquidated damages will be levied for delayed supplyLiquidated damages will be levied for delayed supply (0.5% per day subject to a maximum of 15%)(0.5% per day subject to a maximum of 15%) If the product fails in quality test , the entire batch willIf the product fails in quality test , the entire batch will be returned to the supplier.be returned to the supplier.
  • 20. Drug DistributionDrug Distribution TNMSCTNMSC Head OfficeHead Office Other InstitutionsOther Institutions Medical InstitutionsMedical Institutions Head of DeptHead of Dept Ware HouseWare House SupplierSupplier Requirement Requirement Requirement Requirement Purchase O rder Purchase O rder SuppliesSupplies Supplies Supplies Indents Indents Issue of Issue of Passbooks Passbooks
  • 21. Paracetamol Tab 13.14 11.95 11.5 11.42 11.24 12.4 Co-Trimaxazole Tab 31 27.85 27.3 27.82 27.82 24.88 Cephataxime Sodium Inj 8.31 5.67 5.24 5.08 4.94 4.41 Ciprofloxacin Inj 8 7.5 7.2 6.75 6.74 6.41 Rantidine HCL Tab 31.2 28 26 23.9 22.34 22.05 Ciprofloxacin Tab 168 129.6 99.9 93.03 88 82 Omperazole Cap 86 67 49.9 44 38.57 33.08 Rate Comparison Details (Last 5 Years) 0 20 40 60 80 100 120 140 160 180 Drug Name ValueinRs. 98-99 13.14 31 8.31 8 31.2 168 86 99-00 11.95 27.85 5.67 7.5 28 129.6 67 00-01 11.5 27.3 5.24 7.2 26 99.9 49.9 01-02 11.42 27.82 5.08 6.75 23.9 93.03 44 02-03 11.24 27.82 4.94 6.74 22.34 88 38.57 03-04 12.4 24.88 4.41 6.41 22.05 82 33.08 Paracetamol Tab Co- Trimaxazole Tab Cephataxime Sodium Inj Ciprofloxacin Inj Rantidine HCL Tab Ciprofloxacin Tab Omperazole Cap
  • 22. Sl. No. DRUG NAME UNIT TNMSC AP KAR 1 Aspirin Tab. I.P. - 300 mg 10 X 10 Tabs 11.70 12.00 14.00 2 Prednisolone Tab. I.P. - 5 mg 10 X 10 Tabs 22.90 28.00 28.00 3 Acetazolamide Tab. I.P. - 250 mg 10 X 10 Tabs 41.13 54.00 58.00 4 Ketamine Inj. I.P. - 50 mg/ml 10 ml Vial 14.00 23.00 20.00 5 Thiopentone Sodium Inj. I.P. - 500 mg 20 ml Vial 15.50 26.00 30.00 6 Folic Acid Tab. I.P. - 5 mg 10 X 10 Tabs 5.86 6.00 6.00 7 Diethylcarbamazine Citrate Tab. I.P. - 100 mg 10 X 10 Tabs 7.35 8.00 11.00 8 Choloroquine Phosphate Tab. I.P. - 250 mg 10 X 10 Tabs 23.77 27.00 30.00 9 Silver Sulphadiazine Cream U.S.P. 50 gms Tube 6.03 21.00 16.00 10 Phenobarbitone Tab. I.P. - 30 mg 10 X 10 Tabs 7.66 12.00 10.00 11 ORS Powder I.P. Pouches 27.9 gms 1.56 1.58 1.58 12 Hydrocortisone Sodium Succinate Inj. I.P. - 100mg100 mg/Vial 9.27 12.00 11.00 13 Frusemide Tab. I.P. - 40 mg 10 X 10 Tabs 13.38 14.00 16.00 14 Frusemide Inj. I.P. - 10 mg/ml 2 ml Amp 0.76 0.86 0.95 15 Metaclopramide Inj. I.P. - 10 mg/2 ml 2 ml Amp 0.74 0.85 0.96 16 Rantidine Hcl Inj. I.P. - 50 mg/2 ml 2 ml Amp 0.76 0.82 0.90 17 Rantidine Hcl Tab. I.P. - 150 mg 10 X 10 Tabs 22.34 23.00 30.00 18 Metroniadazole Inj. I.P. - 500mg/100ml 100 ml FFS Bottle 5.25 6.25 6.75 19 Pheniramine Maleate Inj. I.P. (IM or Slow IV Inj.) 2 ml Amp 0.77 0.82 0.92 20 Peritonial Dialysis Solution I.P. - 1000 ml 1000 ml Bottle 13.45 14.25 18.00 COMPARISON OF RATES 2002-COMPARISON OF RATES 2002- 0303
  • 23. Sl. No. DRUG NAME UNIT TNMSC AP KAR 21 Paracetamol Tab. I.P. - 500 mg 10 X 10 Tabs 11.24 13.00 14.00 22 Diazepam Tab. I.P. - 5 mg 10 X 10 Tabs 3.96 4.00 7.00 23 Dexamethasone Sodium Phosphate Inj. I.P. - 8mg/2ml2 ml Vial 2.10 3.00 3.75 24 Pentazocine Lactate Inj. I.P. - 30 mg/ml 1 ml Amp 2.82 2.95 3.10 25 Adrenaline Inj. I.P. - 1 mg/ml 1 ml Amp 0.84 0.92 0.92 26 Atropine Sulphate Inj. I.P. - 0.6 mg/1 ml 2 ml Amp 0.59 0.59 0.62 27 Chlorpheniramine Maleate Tab. I.P. - 4 mg 10 X 10 Tabs 2.40 3.20 4.20 28 Paracetamol Oral Solution U.S.P. XXII - 150 mg/ml15 ml Bottle 4.56 4.90 4.95 29 Ibuprofen Tab. I.P. - 400 mg 10 X 10 Tabs 22.60 24.00 23.00 30 Paracetamol Inj. - 150 mg/ml 2 ml Amp 0.92 0.95 0.96 31 Diclofenac Sodium Inj. I.P. - 25mg/ml 3 ml Amp 0.81 0.85 0.96 32 Glybenclamide Tab.I.P. - 5 mg 10 X 10 Tabs 5.19 8.25 9.00 33 Neostigmine Inj. I.P. - 0.5 mg/ml 0.5 mg/ml Amp 0.95 8.50 2.50 34 Ascorbic Acid Tab. I.P. - 100 mg 10 X 10 Tabs 10.62 43.00 38.00 35 Metformin Tab. I.P. - 500 mg 10 X 10 Tabs 15.90 17.50 16.50 36 Imipramine Tab. I.P. - 25 mg 10 X 10 Tabs 11.70 17.00 16.50 37 Haloperidol Tab. I.P. - 5 mg 10 X 10 Tabs 8.82 20.00 18.00 38 Lignocaine Hcl Inj. I.P. 30 ml Vial 2.95 2.75 7.75 39 Mannitol Inj. I.P. 350 ml Bottle 22.45 25.00 36.00 40 Bupivacaine Inj. I.P. 20 ml Vial 16.95 20.00 28.00 41 Ciprofloxacin Eye Drops U.S.P. 5 ml Vial 2.03 4.00 4.90 COMPARISON OF RATES 2002-COMPARISON OF RATES 2002- 0303
  • 24.
  • 26. Stock Accounting in Ware housesStock Accounting in Ware houses • 1 – Inward Goods Register1 – Inward Goods Register • 2 – Material Receipt Certificate (MRC)2 – Material Receipt Certificate (MRC) • 3 – Q.C. Samples Outward3 – Q.C. Samples Outward • 4 – Stock Register4 – Stock Register • 5 – BIN Card5 – BIN Card • 6 – Inward Indent/Issue Form6 – Inward Indent/Issue Form • 7 – Outward Goods Register7 – Outward Goods Register • 8 – Frozen Stock Register8 – Frozen Stock Register
  • 27. QUALITYQUALITY CONTROLCONTROL Samples from Warehouses Eliminating Common Batches Sent to LAB Receipt of Results QUALITY withQUALITY with no Compromiseno Compromise If Passed Distribution to Institutions If Failed return To supplier If fails, samples are sent to G.A. and another lab for confirmation
  • 28. DEDUCTION FOR QUALITY FAILUREDEDUCTION FOR QUALITY FAILURE If the product fails in quality test, the product will not be accepted andIf the product fails in quality test, the product will not be accepted and returned to the supplier.returned to the supplier. Even if the field samples taken by the Drug Inspector fails in qualityEven if the field samples taken by the Drug Inspector fails in quality test the cost of the quantity remaining unutilized will be recovered fromtest the cost of the quantity remaining unutilized will be recovered from the supplier apart from the levying of other penalties / punishmentsthe supplier apart from the levying of other penalties / punishments including blacklisting.including blacklisting. If there is any complaint from the Medical Officer about the quality ofIf there is any complaint from the Medical Officer about the quality of the product the remaining quantity in the particular batch will be returnedthe product the remaining quantity in the particular batch will be returned to the supplier and value equal to the quantity returned will be recovered.to the supplier and value equal to the quantity returned will be recovered.
  • 29. PROCEDURE FORPROCEDURE FOR BLACKLISTINGBLACKLISTING • In case during the contract period the supplier fails to execute threeIn case during the contract period the supplier fails to execute three consecutive purchase orders issued in full within 90 days then theconsecutive purchase orders issued in full within 90 days then the product will be blacklisted for the firm after giving due opportunity theproduct will be blacklisted for the firm after giving due opportunity the firm to explain the reason for the non execution of purchase orders.firm to explain the reason for the non execution of purchase orders. • During the contract period if two batches of the particular itemDuring the contract period if two batches of the particular item supplied by the firm fails in quality test (Assay content) the product ofsupplied by the firm fails in quality test (Assay content) the product of that particular firm will be blacklisted.that particular firm will be blacklisted. • During the contract period if three batches of the particular itemDuring the contract period if three batches of the particular item supplied by the firm fails in quality test (description test and othersupplied by the firm fails in quality test (description test and other parameters mentioned in pharmocopeia / As per IS specification) thenparameters mentioned in pharmocopeia / As per IS specification) then that particular item will be blacklisted for the firm.that particular item will be blacklisted for the firm. • In respect of the firm supplying more than one item during theIn respect of the firm supplying more than one item during the contract period if more than 50% of the items are blacklisted based oncontract period if more than 50% of the items are blacklisted based on the above process then the firm will be blacklisted.the above process then the firm will be blacklisted.
  • 30.   Description 98-99 99-2000 2000-01 2001-02 2002-03 No. of Samples Sent to QC Lab 10065 10185 10476 11065 12012 No. of Samples Passed 9736 9874 10186 10824 11844 No. of Samples Failed 329 311 290 241 168 % Passed 96.73 96.94 97.23 97.82 98.60 % of Failure 3.26 3.05 2.76 2.17 1.40   Assessment of Samples Sent for QC TestAssessment of Samples Sent for QC Test 2003-04 14778 14600 178 98.8 1.20
  • 31. Management InformationManagement Information System-MISSystem-MIS • Exceptional Stock Statement • Slow Moving Drug List • Drug Order Statement • Passbook Utilisation Report • Unexecuted Order Statement • Abstract Pending Bills Report • Time Expiry Drugs • Abstract Order & Supplied Value Report
  • 32. Diagnostics ServicesDiagnostics Services   (i) ISO 9001:2000 certified GI Bleed and Hepatobiliary Centre(i) ISO 9001:2000 certified GI Bleed and Hepatobiliary Centre (Special Ward) maintained by TNMSC is functioning as a(Special Ward) maintained by TNMSC is functioning as a separate unit under the Surgical Gastroentrology Department inseparate unit under the Surgical Gastroentrology Department in Government Stanley Hospital, Chennai.Government Stanley Hospital, Chennai. (ii) TNMSC is maintaining the Master Health Checkup Scheme at(ii) TNMSC is maintaining the Master Health Checkup Scheme at Government General Hospital, Chennai.Government General Hospital, Chennai. (iii) TNMSC is maintaining the Special Class Maternity Ward in(iii) TNMSC is maintaining the Special Class Maternity Ward in IOG, Chennai-8.IOG, Chennai-8. (iv) TNMSC has provided infrastructure facilities to the payment(iv) TNMSC has provided infrastructure facilities to the payment ward in Govt. Kasturba Gandhi Hospital, chennai-5 and startedward in Govt. Kasturba Gandhi Hospital, chennai-5 and started maintaining the same from 03-05-2004.maintaining the same from 03-05-2004.
  • 33. TNMSC CT Scan CenterTNMSC CT Scan Center TNMSC is maintaining 36 CT Scan Centres inTNMSC is maintaining 36 CT Scan Centres in Govt. Hospitals.Govt. Hospitals. The following charges are collected for scanning.The following charges are collected for scanning. Category Plain With ContrastCategory Plain With Contrast Inpatients Rs. 350/- Rs. 550/-Inpatients Rs. 350/- Rs. 550/- Outpatients Rs. 500/- Rs. 700/-Outpatients Rs. 500/- Rs. 700/-
  • 34. TNMSC MRI Scan CenterTNMSC MRI Scan Center TNMSC is maintaining 1.5 Tesla MRI atTNMSC is maintaining 1.5 Tesla MRI at - Govt. General Hospital, Chennai.- Govt. General Hospital, Chennai. - Govt. Rajaji Hospital, Madurai.- Govt. Rajaji Hospital, Madurai. CategoryCategory PlainPlain With ContrastWith Contrast Larger PartsLarger Parts Rs. 3500/- EachRs. 3500/- Each Rs. 5000/- EachRs. 5000/- Each Smaller PartsSmaller Parts Rs. 2500/- EachRs. 2500/- Each Rs. 4000/- EachRs. 4000/- Each
  • 35. Purchase and Supply ofPurchase and Supply of equipments to hospitalsequipments to hospitals TNMSC has finalized rate contract (CPC System) through openTNMSC has finalized rate contract (CPC System) through open tender for the purchase of equipments & accessories required fortender for the purchase of equipments & accessories required for 19 departments in Government hospitals consisting of about 307819 departments in Government hospitals consisting of about 3078 items for the period 2002-2004. The medical institutions canitems for the period 2002-2004. The medical institutions can directly place purchase orders with the approved firms for thedirectly place purchase orders with the approved firms for the supply of required equipments and accessories at the approvedsupply of required equipments and accessories at the approved rates depending upon the budget provision.rates depending upon the budget provision. The medical equipments required for the governmentThe medical equipments required for the government hospitals are procured and supplied by TNMSC based onhospitals are procured and supplied by TNMSC based on the Government order issued for this purpose from time tothe Government order issued for this purpose from time to timetime
  • 36. Construction Activities ofConstruction Activities of TNMSCTNMSC (i) Implementation of World Bank Assisted RCH Project(i) Implementation of World Bank Assisted RCH Project    Under this project, construction of Buildings for 8 UHPs and 21 HSCs andUnder this project, construction of Buildings for 8 UHPs and 21 HSCs and improvement works in 35 PHCs and 70 HSCs for Rs.5.65 Crores have beenimprovement works in 35 PHCs and 70 HSCs for Rs.5.65 Crores have been completed by TNMSC in Madurai & Theni Districts.completed by TNMSC in Madurai & Theni Districts.    (ii) Regional Diagnostic Centres(ii) Regional Diagnostic Centres    TNMSC has established 7 Regional Diagnostic centres in the State (BuildingTNMSC has established 7 Regional Diagnostic centres in the State (Building and Equipment) at Thiruvannamalai, Villupuram, Pudukottai, Virudhunagar,and Equipment) at Thiruvannamalai, Villupuram, Pudukottai, Virudhunagar, Ramanathapuram, Nammakkal and Tiruppur at a total cost of Rs.21.00 CroresRamanathapuram, Nammakkal and Tiruppur at a total cost of Rs.21.00 Crores funded by the Government of India.funded by the Government of India. (iii) Accident and Emergency Ward (Trauma Care Centre)(iii) Accident and Emergency Ward (Trauma Care Centre) Construction and procurement of equipments for the Accident and EmergencyConstruction and procurement of equipments for the Accident and Emergency ward at Ambur, Krishnagiri, Tindivanam, Sriperumbudur and Kovilpatti have beenward at Ambur, Krishnagiri, Tindivanam, Sriperumbudur and Kovilpatti have been completed at a cost of Rs.2.93 Crores provided by the Home Department.completed at a cost of Rs.2.93 Crores provided by the Home Department.
  • 37. Consultancy ServicesConsultancy Services TNMSC is a Role Model for other states of India onTNMSC is a Role Model for other states of India on Drug Logistics and Warehousing.Drug Logistics and Warehousing. TNMSC has taken up and completed the consultancyTNMSC has taken up and completed the consultancy project for the preparation of Feasibility report forproject for the preparation of Feasibility report for Andhra Pradesh.Andhra Pradesh. Govt. of Rajasthan has entrusted preparation ofGovt. of Rajasthan has entrusted preparation of feasibility report to TNMSC. Draft Final reportfeasibility report to TNMSC. Draft Final report submitted to Govt. of Rajasthan.submitted to Govt. of Rajasthan. Training course on Drug Logistics and WarehousingTraining course on Drug Logistics and Warehousing has been conducted for Pharmacists, H & FWhas been conducted for Pharmacists, H & FW department , Govt. of Karnataka during May 2003department , Govt. of Karnataka during May 2003 and for Pharmacists, H & FW department , Govt. ofand for Pharmacists, H & FW department , Govt. of Assam during June 2004.Assam during June 2004.
  • 38.
  • 39. ThanksThanks Email me : arputhaselvaraj@gmail.comEmail me : arputhaselvaraj@gmail.com